{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:15:25Z","timestamp":1778710525710,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004621","name":"Kerman University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.pbb.2014.03.002","type":"journal-article","created":{"date-parts":[[2014,3,13]],"date-time":"2014-03-13T18:12:20Z","timestamp":1394734340000},"page":"133-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Peroxisome proliferator-activated receptor-\u03b3 activation attenuates motor and cognition impairments induced by bile duct ligation in a rat model of hepatic cirrhosis"],"prefix":"10.1016","volume":"120","author":[{"given":"Iraj","family":"Aghaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikta","family":"Doustar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Nazeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmadreza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2014.03.002_bb0005","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/00000542-200512000-00010","article-title":"Memory enhancing effect of low-dose sevoflurane does not occur in basolateral amygdala-lesioned rats","volume":"103","author":"Alkire","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pbb.2014.03.002_bb0010","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbr.2010.07.033","article-title":"Acute but not chronic administration of pioglitazone promoted behavioral and neurochemical protective effects in the MPTP model of Parkinson's disease","volume":"216","author":"Barbiero","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2014.03.002_bb0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1023\/A:1021989230535","article-title":"Pathophysiology of hepatic encephalopathy: a new look at ammonia","volume":"17","author":"Butterworth","year":"2002","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.pbb.2014.03.002_bb0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s12640-010-9185-z","article-title":"Metal toxicity, liver disease and neurodegeneration","volume":"18","author":"Butterworth","year":"2010","journal-title":"Neurotox Res"},{"key":"10.1016\/j.pbb.2014.03.002_bb0025","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/hep.24228","article-title":"Hepatic encephalopathy: a central neuroinflammatory disorder?","volume":"53","author":"Butterworth","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.pbb.2014.03.002_bb0030","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1478-3231.2009.02034.x","article-title":"Experimental models of hepatic encephalopathy: ISHEN guidelines","volume":"29","author":"Butterworth","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.pbb.2014.03.002_bb0035","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nrn3587","article-title":"Hepatic encephalopathy: effects of liver failure on brain function","volume":"14","author":"Felipo","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pbb.2014.03.002_bb0040","article-title":"PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases","volume":"34","author":"Fruchart","year":"2006","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.pbb.2014.03.002_bb0045","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.neuroscience.2013.07.049","article-title":"Maternal mobile phone exposure adversely affects the electrophysiological properties of Purkinje neurons in rat offspring","volume":"250","author":"Haghani","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2014.03.002_bb0050","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbr.2011.12.008","article-title":"Female rats are more susceptible to the deleterious effects of paradoxical sleep deprivation on cognitive performance","volume":"228","author":"Hajali","year":"2012","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2014.03.002_bb0055","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.bbr.2013.08.018","article-title":"Effects of CA1 glutamatergic systems upon memory impairments in cholestatic rats","volume":"256","author":"Hosseini","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2014.03.002_bb0060","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1203\/PDR.0b013e31818d5bc7","article-title":"Melatonin ameliorates bile duct ligation-induced systemic oxidative stress and spatial memory deficits in developing rats","volume":"65","author":"Huang","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.pbb.2014.03.002_bb0065","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/FBP.0b013e3283618a8c","article-title":"Nitric oxide mediates the beneficial effect of chronic naltrexone on cholestasis-induced memory impairment in male rats","volume":"24","author":"Javadi-Paydar","year":"2013","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2014.03.002_bb0070","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/hep.21180","article-title":"Brain edema and inflammatory activation in bile duct ligated rats with diet\u2010induced hyperammonemia: a model of hepatic encephalopathy in cirrhosis","volume":"43","author":"Jover","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.pbb.2014.03.002_bb0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pbb.2010.04.018","article-title":"Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-\u03d2 (PPAR\u03d2) in Huntington's disease","volume":"96","author":"Kalonia","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2014.03.002_bb0080","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2741\/2802","article-title":"Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists","volume":"13","author":"Kapadia","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.pbb.2014.03.002_bb0085","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2337\/diab.43.2.204","article-title":"Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys","volume":"43","author":"Kemnitz","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.pbb.2014.03.002_bb0090","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.bbr.2008.10.010","article-title":"Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease","volume":"197","author":"Kumar","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2014.03.002_bb0095","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0091-3057(96)00386-3","article-title":"Ethanol preference, metabolism, blood pressure, and conditioned taste aversion in experimental cholestasis","volume":"57","author":"Lane","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2014.03.002_bb0100","first-page":"1","article-title":"Impairment of short term memory in rats with hepatic encephalopathy due to bile duct ligation","author":"Leke","year":"2012","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.pbb.2014.03.002_bb0105","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1476-5381.2009.00589.x","article-title":"Cannabidiol ameliorates cognitive and motor impairments in bile\u2010duct ligated mice via 5\u2010HT1A receptor activation","volume":"159","author":"Magen","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2014.03.002_bb0110","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jhep.2009.04.021","article-title":"Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation","volume":"51","author":"Magen","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.pbb.2014.03.002_bb0115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brainresbull.2011.03.011","article-title":"Protective effect of pioglitazone, a PPAR\u03b3 ligand, in a 3 nitropropionic acid model of Huntington's disease","volume":"85","author":"Napolitano","year":"2011","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pbb.2014.03.002_bb0120","first-page":"2008","article-title":"Cholestasis impaired spatial and non-spatial novelty detection in mice","volume":"4","author":"Nasehi","year":"2013","journal-title":"J. Paramed. Sci."},{"key":"10.1016\/j.pbb.2014.03.002_bb0125","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1124\/jpet.106.113472","article-title":"Thiazolidinedione class of peroxisome proliferator-activated receptor \u03b3 agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats","volume":"320","author":"Park","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2014.03.002_bb0130","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/1440-1681.12144","article-title":"Pioglitazone alleviates the mitochondrial apoptotic pathway and mito\u2010oxidative damage in the d\u2010galactose\u2010induced mouse model","volume":"40","author":"Prakash","year":"2013","journal-title":"Clin Exp Pharmacol P"},{"key":"10.1016\/j.pbb.2014.03.002_bb0135","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/fcp.12015","article-title":"Pharmacological blockade of TRPV1 receptors modulates the effects of 6\u2010OHDA on motor and cognitive functions in a rat model of Parkinson's disease","volume":"27","author":"Razavinasab","year":"2013","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pbb.2014.03.002_bb0140","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.expneurol.2010.10.003","article-title":"Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury","volume":"227","author":"Sauerbeck","year":"2011","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pbb.2014.03.002_bb0145","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2014.03.002_bb0150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuroscience.2010.10.031","article-title":"Maternal exposure to the CB1 cannabinoid agonist WIN 55212-2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurons in rat offspring","volume":"172","author":"Shabani","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2014.03.002_bb0155","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.neuro.2012.08.004","article-title":"Walnut consumption protects rats against cisplatin-induced neurotoxicity","volume":"33","author":"Shabani","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.pbb.2014.03.002_bb0160","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/15209150050194297","article-title":"Thiazolidinediones: a comparative review of approved uses","volume":"2","author":"Sood","year":"2000","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.pbb.2014.03.002_bb0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1742-2094-8-91","article-title":"The PPAR-g agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys","volume":"8","author":"Swanson","year":"2011","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.pbb.2014.03.002_bb0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jneuroim.2007.09.029","article-title":"Neuroprotection with pioglitazone against LPS insult on dopaminergic neurons may be associated with its inhibition of NF-\u03baB and JNK activation and suppression of COX-2 activity","volume":"192","author":"Xing","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.pbb.2014.03.002_bb0175","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1460-9568.2005.04200.x","article-title":"The intracerebral application of the PPAR\u03b3\u2010ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain","volume":"22","author":"Zhao","year":"2005","journal-title":"Eur J Neurosci"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305714000720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305714000720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:32:39Z","timestamp":1758774759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305714000720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":35,"alternative-id":["S0091305714000720"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2014.03.002","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peroxisome proliferator-activated receptor-\u03b3 activation attenuates motor and cognition impairments induced by bile duct ligation in a rat model of hepatic cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2014.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}